Abeona Therapeutics Inc’s filing revealed that its Chief Financial Officer Vazzano Joseph Walter unloaded Company’s shares for reported $9975.0 on Jul 22 ’25. In the deal valued at $6.64 per share,1,502 shares were sold. As a result of this transaction, Vazzano Joseph Walter now holds 477,666 shares worth roughly $3.07 million.
Then, Vazzano Joseph Walter bought 1,502 shares, generating $9,975 in total proceeds.
Before that, Silverstein Christine Berni sold 13,093 shares. Abeona Therapeutics Inc shares valued at $76,669 were divested by the Director at a price of $5.86 per share. As a result of the transaction, Silverstein Christine Berni now holds 120,479 shares, worth roughly $0.77 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early March with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering ABEO with “Buy” recommendation on July 03, 2024. Stifel started covering the stock on May 30, 2024. It rated ABEO as “a Buy”.
Price Performance Review of ABEO
On Monday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock fall -1.08% to $6.42. Over the last five days, the stock has lost -3.02%. Abeona Therapeutics Inc shares have risen nearly 31.02% since the year began. Nevertheless, the stocks have risen 15.26% over the past one year.
How much short interest is there in Abeona Therapeutics Inc?
A steep rise in short interest was recorded in Abeona Therapeutics Inc stocks on 2025-07-15, growing by 2.02 million shares to a total of 8.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 6.46 million shares. There was a rise of 23.8%, which implies that there is a positive sentiment for the stock.
